ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
277.70
+4.20 (1.54%)
At close: Jul 29, 2025, 4:00 PM
280.00
+2.30 (0.83%)
After-hours: Jul 29, 2025, 7:29 PM EDT

ResMed Stock Forecast

Stock Price Forecast

The 13 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $263.91, which forecasts a -4.97% decrease in the stock price over the next year. The lowest target is $180 and the highest is $294.

Price Target: $263.91 (-4.97%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$180$263.91$270$294
Change-35.18%-4.97%-2.77%+5.87%

Analyst Ratings

The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy233333
Buy334446
Hold655553
Sell111111
Strong Sell000000
Total121213131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Upgrades
$255$294
BuyUpgrades$255$294+5.87%Jul 16, 2025
Mizuho
Mizuho
Buy
Maintains
$250$270
BuyMaintains$250$270-2.77%Jul 16, 2025
RBC Capital
RBC Capital
Hold
Maintains
$247$255
HoldMaintains$247$255-8.17%Apr 24, 2025
UBS
UBS
Strong Buy
Maintains
$290$285
Strong BuyMaintains$290$285+2.63%Apr 24, 2025
JP Morgan
JP Morgan
Buy
Maintains
$286$290
BuyMaintains$286$290+4.43%Apr 24, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
5.17B
from 4.69B
Increased by 10.37%
Revenue Next Year
5.58B
from 5.17B
Increased by 7.85%
EPS This Year
9.58
from 6.92
Increased by 38.51%
EPS Next Year
10.58
from 9.58
Increased by 10.38%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
2.96B3.20B3.58B4.22B4.69B5.17B5.58B5.97B
Revenue Growth
13.45%8.11%11.93%18.02%10.95%10.37%7.85%7.05%
EPS
4.273.245.306.096.929.5810.5811.58
EPS Growth
52.50%-24.12%63.58%14.91%13.63%38.51%10.38%9.48%
Forward PE
-----28.9726.2523.98
No. Analysts
-----202015
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High5.4B5.9B6.4B
Avg5.2B5.6B6.0B
Low5.0B5.3B5.6B

Revenue Growth

Revenue Growth20252026202720282029
High
15.3%
14.2%
14.5%
Avg
10.4%
7.9%
7.0%
Low
6.7%
2.8%
0.9%

EPS Forecast

EPS20252026202720282029
High10.3611.7213.00
Avg9.5810.5811.58
Low8.969.8010.38

EPS Growth

EPS Growth20252026202720282029
High
49.8%
22.3%
22.9%
Avg
38.5%
10.4%
9.5%
Low
29.4%
2.2%
-1.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.